Articles

The cost-of-living adjustment can’t keep up with the actual cost of living, as retirees’ costs climb.

Novo Nordisk, the Danish drugmaker behind Ozempic and other weight-loss drugs, said it’s paying up to $5.2 billion to buy Akero Therapeutics, a biotech with a drug in a late-stage trial to treat a fatal liver disease.

PepsiCo saw an earnings beat and an improved full-year outlook, even as beverage volumes in North America extended their long streak of declines.

Steve Englander opines, “a productivity-driven increase in real interest rates is the most powerful driver a currency can have”

“I read that the Social Security Disability Insurance Trust Fund is good until 2099.”

Rappers Cardi B and Nicki Minaj have reignited their longstanding feud by engaging in a furious war of words on social media recently, but they both have made impressive home buys.

HSBC Holdings on Thursday said it was offering a 30% premium to buy just over the one-third of Hang Seng Bank it didn’t already own.

Inflation worries are lingering on the minds of investors, even if Treasury yields were little changed Wednesday by the release of minutes of the Federal Reserve’s last policy meeting.

Costco Wholesale Corp. on Wednesday said it notched an 8% year-over-year sales gain through last month, continuing its streak of sales gains and easing Wall Street’s concerns about future growth.

Higher costs of living, slowing pet adoptions and a preference toward cats and smaller dogs have kept high-end pet-food maker Freshpet Inc. in the doghouse, BofA analysts said Wednesday.

The government shutdown might delay the 2026 filing season’s start, one expert notes.

The ETF’s biggest holding is Opendoor, a name that has sparked comparisons with the meme-stock explosion of 2021